 |
인쇄하기
취소
|
Korean antihypertensive drugs increase market share
Korean-made antihypertensive drugmakers have taken up bigger share in the final quarter of last year, an industry report showed recently.
According to UBIST data, Chong Kun Dang Pharmaceutical’s Salotan (losartan) and Yuhan Corporation’s Losartan accounted for 17.8 percent and 9.8 percent of sales volume, respectively. Cozaar by MSD Korea continued to lead the market.
Domestic firms put ...
According to UBIST data, Chong Kun Dang Pharmaceutical’s Salotan (losartan) and Yuhan Corporation’s Losartan accounted for 17.8 percent and 9.8 percent of sales volume, respectively. Cozaar by MSD Korea continued to lead the market.
Domestic firms put ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.